A correlation between increased platelet adhesiveness and aggregation and the development of angiopathy in diabetes mellitus can be made. Thromboxane produced by platelets represents a potent platelet aggregation factor. We studied the platelet TXB2 production during blood coagulation in carefully selected patients with type II diabetes mellitus in good metabolic control and the results were correlated with the presence or absence of microangiopathy, fasting blood glucose levels, type of therapy, age, duration of diabetes and the most important hematochemical parameters. No statistically significant differences were found between serum TXB2 concentrations in diabetic patients and control subjects, in diabetics with or without microangiopathy and in diabetics on insulin therapy or on oral hypoglycemic agents. We did not observe any correlation between TXB2 production and age, duration of diabetes, sex, basal blood glucose levels, total and HDL-cholesterol, triglycerides, blood creatinine and blood electrolytes. The thromboxane production may be a not important factor for determining the increased platelet aggregation which is at the origin of the angiopathy in diabetes mellitus. © 1986 Casa Editrice «Il Ponte».

Altomonte, L., Zoli, A., Mangia, A., Ghirlanda, G., Manna, R., Bertoli, A., Greco, A. V., Thromboxane production in diabetes mellitus, <<LA RICERCA IN CLINICA E IN LABORATORIO>>, 1986; 16 (4): 539-542. [doi:10.1007/BF02886836] [http://hdl.handle.net/10807/173613]

Thromboxane production in diabetes mellitus

Altomonte, Lorenzo;Zoli, Angelo
Secondo
Membro del Collaboration Group
;
Mangia, Alessandro;Manna, Raffaele;Bertoli, Alessia;
1986

Abstract

A correlation between increased platelet adhesiveness and aggregation and the development of angiopathy in diabetes mellitus can be made. Thromboxane produced by platelets represents a potent platelet aggregation factor. We studied the platelet TXB2 production during blood coagulation in carefully selected patients with type II diabetes mellitus in good metabolic control and the results were correlated with the presence or absence of microangiopathy, fasting blood glucose levels, type of therapy, age, duration of diabetes and the most important hematochemical parameters. No statistically significant differences were found between serum TXB2 concentrations in diabetic patients and control subjects, in diabetics with or without microangiopathy and in diabetics on insulin therapy or on oral hypoglycemic agents. We did not observe any correlation between TXB2 production and age, duration of diabetes, sex, basal blood glucose levels, total and HDL-cholesterol, triglycerides, blood creatinine and blood electrolytes. The thromboxane production may be a not important factor for determining the increased platelet aggregation which is at the origin of the angiopathy in diabetes mellitus. © 1986 Casa Editrice «Il Ponte».
1986
Inglese
Altomonte, L., Zoli, A., Mangia, A., Ghirlanda, G., Manna, R., Bertoli, A., Greco, A. V., Thromboxane production in diabetes mellitus, <<LA RICERCA IN CLINICA E IN LABORATORIO>>, 1986; 16 (4): 539-542. [doi:10.1007/BF02886836] [http://hdl.handle.net/10807/173613]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/173613
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact